Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Liver Disease
80%
Irritable Bowel Syndrome
66%
Prevalence
51%
Diseases
44%
Diagnosis
42%
Gut
40%
Chronic Liver Disease
35%
Enteropathy
33%
Cross Sectional Study
33%
Ciclonicate
33%
Outpatient
33%
Risk Stratification
33%
Circadian Rhythm
33%
Transient Elastography
33%
Myofibroblast
33%
Secondary Care
31%
Liver Fibrosis
27%
Hepatic Stellate Cell
20%
Symptom
19%
Pathophysiology
18%
Biological Marker
17%
Body Mass Index
15%
Fibrosis
13%
Chronic Disease
13%
Diagnostic Accuracy
11%
Maturity Onset Diabetes of the Young
11%
Clinical Pathway
11%
Enzyme Assay
11%
Diabetes
11%
Diagnostic Test
11%
Liver Enzyme
11%
Alcohol Consumption
11%
Endoscopy
8%
Gastrointestinal Bleeding
8%
Gastroscopy
8%
Gut Microbiome
6%
Liver Cirrhosis
6%
Translating (Language)
6%
Abdominal Pain
6%
Bloating
6%
Defecation Habit
6%
Epidemic
6%
Extracellular Matrix
6%
Rho Guanine Nucleotide Dissociation Inhibitor
6%
Premature Mortality
6%
Liver Function Test
6%
Respiratory Disease
6%
Bacterial Overgrowth
6%
Metabolic Syndrome
6%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
33%
Ciclonicate
33%
Nonalcoholic Fatty Liver
33%
Fibrosis
22%
Chronic Disease
22%
Liver Disease
22%
Metabolic Syndrome X
11%
Inflammation
11%
Carcinoma
11%
Liver Fibrosis
11%
Biological Marker
11%
Disease Exacerbation
11%
Injury
11%
Rho Guanine Nucleotide Dissociation Inhibitor
11%
Disease Severity
11%
Gastrointestinal Hemorrhage
8%
Symptom
8%
Nursing and Health Professions
Disease Detection
33%
Liver Disease
33%
Transient Elastography
33%
Diagnosis
26%
Secondary Health Care
13%
Chronic Liver Disease
13%
Enzyme Assay
11%
Primary Medical Care
6%
Patient Care
6%
Liver Cirrhosis
6%
Model of Care
6%
Treatment Outcome
6%
Disease
6%
Respiratory Tract Disease
6%
Epidemic
6%
Early Diagnosis
6%
Premature Mortality
6%
